

Purpose: We investigated the role of serum uric acid (sUA) and superoxide dismutase (SOD) as predictive factors for mortality in hemodialysis (HD) patients. Methods: SOD, butyrylcholinesterase, and malondialdehyde were estimated spectrophotometrically and the other parameters by standard procedures. High-sensitive C-reactive protein was assayed by a sandwich ELISA method. Results: sUA among survivors (112.1 ± 13.82 μmol/L) was significantly lower than in deceased (160.8 ± 16.81 μmol/L, p < 0.001), while SOD was higher in survivors (31.8 ± 6.61 kU/L) than among deceased (20.2 ± 3.03, p < 0.05). Kaplan-Meier survival curves showed the greatest mortality risk in the highest tertile of basal sUA concentration (≥127.11 μmol/L, p < 0.001), and for SOD in the lowest tertile (≤23.83 kU/L, p < 0.05). Conclusion: Our results suggest that high sUA and low SOD may predict all-cause and cardiovascular mortality in HD patients. © 2012 Springer Science+Business Media, B.V.
| EMTREE drug terms: | superoxide dismutaseuric acid |
|---|---|
| EMTREE medical terms: | adultarticlecardiovascular mortalityenzyme blood levelfemalehemodialysishemodialysis patienthumanmajor clinical studymalemortalityprognosisprospective studyrisk assessmentrisk factorsurvivaluric acid blood level |
| MeSH: | AgedBiological MarkersCardiovascular DiseasesCause of DeathCohort StudiesConfidence IntervalsEnzyme-Linked Immunosorbent AssayFemaleHumansKaplan-Meier EstimateKidney Failure, ChronicLogistic ModelsMaleMalondialdehydeMiddle AgedMultivariate AnalysisPredictive Value of TestsPrognosisProspective StudiesRenal DialysisSpectrophotometrySuperoxide DismutaseSurvival AnalysisUric Acid |
superoxide dismutase, 37294-21-6, 9016-01-7, 9054-89-1; uric acid, 69-93-2
| Funding sponsor | Funding number | Acronym |
|---|---|---|
| Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja | 175023,175035 | MPNTR |
| Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja | MPNTR |
Acknowledgments This work was supported by grants from the Ministry of Education and Science, Republic of Serbia (Projects No. 175023 and 175035).
Stefanovic, A.; Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, Serbia;
© Copyright 2013 Elsevier B.V., All rights reserved.